Skip to main content
Log in

Persistent drug use provide economic benefits in DM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA.Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care 32: 647-649, No. 4, Apr 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persistent drug use provide economic benefits in DM. Pharmacoecon. Outcomes News 579, 10 (2009). https://doi.org/10.2165/00151234-200905790-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00019

Keywords

Navigation